Rate My Professor Bruce Mackinnon

Dr. Bruce Mackinnon is a Conjoint Associate Professor in the School of Medicine and Public Health within the College of Health, Medicine and Wellbeing at the University of Newcastle. He concurrently serves as a Senior Staff Specialist Nephrologist in the Department of Nephrology and Transplantation at John Hunter Hospital, Newcastle. Qualified with BSc (Hons), MBChB, MD, FRCP, and FRACP, Mackinnon received his training in Nephrology and General Medicine in the United Kingdom and Australia. During this period, he conducted post-graduate research investigating the progression of chronic kidney disease, earning him the degree of MD.

In 2008, Mackinnon was appointed as a Specialist Nephrologist in Glasgow, Scotland, a role he fulfilled until relocating to Newcastle in 2019. During his time in Scotland, he chaired the National Dialysis and Transplant Registry and sat on the National New Drugs Assessment Committee. His clinical interests include chronic kidney disease, hypertension, glomerulonephritis, vasculitis, and cystic kidney disease. He maintains an active commitment to teaching and research via his conjoint academic appointment at the University of Newcastle. Mackinnon's research specializes in nephrology and transplantation, with his publications accumulating over 3,393 citations. Prominent works encompass 'Are we disadvantaging smokers by excluding them from kidney transplantation? A single-centre experience and survey of kidney transplantation units' (2025), 'Outcomes in ANCA-Associated Vasculitis in Scotland: Validation of the Renal Risk Score in a Complete National Cohort' (2023), 'ANCA-associated renal vasculitis is associated with rurality but not seasonality or deprivation in a complete national cohort study' (2021), 'Hematuria Is Associated with More Severe Acute Tubulointerstitial Nephritis' (2020), 'Predicting outcome in acute interstitial nephritis: a case series examining the importance of histological parameters' (2019), 'Renal risk score performance in a cohort of Scottish patients with ANCA-associated glomerulonephritis' (2019), and 'Obesity is not associated with progression to end stage renal disease in patients with biopsy-proven glomerular diseases' (2019). These contributions address pivotal topics in renal vasculitis, interstitial nephritis, glomerular diseases, and transplant criteria.